The efficacy of nintedanib in 158 patients with idiopathic pulmonary fibrosis in real-world settings: A multicenter retrospective study

BACKGROUND: The INPULSIS trials revealed that nintedanib reduced the decline in lung function in patients with idiopathic pulmonary fibrosis. We aimed to evaluate the efficacy and safety of nintedanib in Japanese idiopathic pulmonary fibrosis patients in real-world settings. METHOD: Medical records...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:SAGE Open Med
Autors principals: Dobashi, Masaki, Tanaka, Hisashi, Taima, Kageaki, Itoga, Masamichi, Ishioka, Yoshiko, Shiratori, Toshihiro, Okumura, Fumihiko, Tabe, Chiori, Tanaka, Yoshihito, Morimoto, Takeshi, Hasegawa, Yukihiro, Yasugahira, Hideo, Okudera, Koichi, Takanashi, Shingo, Tasaka, Sadatomo
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2021
Matèries:
Original Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8188975/
https://ncbi.nlm.nih.gov/pubmed/34164129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20503121211023357
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars